B+
Bull case
25%
Probability
Target price
$6.50
Analysis reference price unavailable
Analysis 2026-09-04 · RankAlpha Sentiment Codex
GNLX
GeneluxANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
The central upside case is a favorable Phase 3 OnPrime/GOG-3076 readout in 2H26, supported by company-reported translational evidence of immune activation and platinum sensitization. Lung-cancer dose-finding updates provide additional platform optionality.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Analyst coverage, recent-news coverage, social data, and verified post-earnings market-reaction data are limited or unavailable.
Momentum
20
Value
41
Sentiment
100
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $3.20 · Bull $6.50 · Bear $1.10Analysis 2026-09-04; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-04 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $19.00
Why
Momentum20 · Δ7d -
Value41 · Δ7d 0.0
Sentiment100 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • Analyst coverage, recent-news coverage, social data, and verified post-earnings market-reaction data are limited or unavailable.
- • Cash resources are expected to fund operations only into 1Q27, creating potential financing and dilution risk.
- • The thesis is highly binary: a weak or unsafe Phase 3 outcome could impair the program and valuation.
Catalyst clock
2026-12-03
Phase 3 OnPrime/GOG-3076 topline data
Lead driver: Sentiment · See AI snapshot
Momentum
20
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
100
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 20.0 / Value 41.2 / Sentiment 100.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-04. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$3.20
Analysis reference price unavailable
Analysis 2026-09-04 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$1.10
Analysis reference price unavailable
Analysis 2026-09-04 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$122.16M
Beta
-
Shares Out
45.25M
P/E (TTM) · Derived
-3.1
P/S (TTM)
-
P/FCF (TTM) · Derived
-3.86
Rev YoY
-100.0%
EPS YoY
+7.2%
Gross Margin
-5925.0%
Op Margin
-391575.0%
Net Debt
-$12.91M
Current Ratio
2.39
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data